Skip to main content
SpringerLink
Log in

Natural Killer Cells and Human Longevity

  • Chapter
Handbook on Immunosenescence

Abstract

Natural killer (NK) cells are a lymphocyte subset in the innate immune system. These cells not only mount an early immune response to infections and neoplasia but also affect the adaptive immune system by communicating with dendritic cells. In this chapter, we review basic findings on NK-cells and then information from 1) rare patients with isolated NK-cell deficiency, 2) patients with certain malignant neoplasia, and 3) healthy middle-aged and elderly individuals. Those findings indicate that NK-cells are crucial immune components for sustaining life. With increasing age, numbers of T- and B-lymphocytes decline while the number of NK-cells increases. This is especially marked in centenarians. In terms of reduced tolerance to stress such as infections in the elderly, the power of early responders in the immune system including NK-cells may be especially important.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adam C, King S et al (2005) “DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction.” Blood 106(1):338–344

    Article  PubMed  CAS  Google Scholar 

  2. Alter G, Malenfant JM et al (2004) “Increased natural killer cell activity in viremic HIV-1 infection.” J Immunol 173(8):5305–5311

    PubMed  CAS  Google Scholar 

  3. Andoniou CE, van Dommelen SL et al (2005) “Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity.” Nat Immunol 6(10):1011–1019

    Article  PubMed  CAS  Google Scholar 

  4. Artavanis-Tsakonas K, Riley EM (2002) “Innate immune response to malaria: rapid induction of IFN-gamma from human NK cells by live Plasmodium falciparum-infected erythrocytes.” J Immunol 169(6):2956–2963

    PubMed  CAS  Google Scholar 

  5. Ballas ZK, Turner JM et al (1990) “A patient with simultaneous absence of “classical “natural killer cells (CD3-, CD16+, and NKH1+) and expansion of CD3+, CD4-, CD8-, NKH1+ subset.” J Allergy Clin Immunol 85(2):453–459

    Article  PubMed  CAS  Google Scholar 

  6. Biron CA, Byron KS et al (1989) “Severe herpesvirus infections in an adolescent without natural killer cells.” N Engl J Med 320(26):1731–1735

    Article  PubMed  CAS  Google Scholar 

  7. Biron CA, Nguyen KB et al (1999) “Natural killer cells in antiviral defense: function and regulation by innate cytokines.” Annu Rev Immunol 17:189–220

    Article  PubMed  CAS  Google Scholar 

  8. Bonaparte MI, E Barker (2004) “Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules.” Blood 104(7):2087–2094

    Article  PubMed  CAS  Google Scholar 

  9. Borrego F, Alonso MC et al (1999) “NK phenotypic markers and IL2 response in NK cells from elderly people.” Exp Gerontol 34(2):253–265

    Article  PubMed  CAS  Google Scholar 

  10. Bottino C, Moretta L et al (2004) “Learning how to discriminate between friends and enemies, a lesson from Natural Killer cells.” Mol Immunol 41(6–7):569–575

    Article  PubMed  CAS  Google Scholar 

  11. Braud VM, Allan DS et al (1998) “HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.” Nature 391(6669):795–799

    Article  PubMed  CAS  Google Scholar 

  12. Caligiuri MA (1993) “Low-dose recombinant interleukin-2 therapy: rationale and potential clinical applications.” Semin Oncol 20(6 Suppl 9):3–10

    PubMed  CAS  Google Scholar 

  13. Campbell JJ, Qin S et al (2001) “Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire.” J Immunol 166(11):6477–6482

    PubMed  CAS  Google Scholar 

  14. Castriconi R, Cantoni C et al (2003) “Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells.” Proc Natl Acad Sci U S A 100(7):4120–4125

    Article  PubMed  CAS  Google Scholar 

  15. Cerwenka A, LL Lanier (2003) “NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer.” Tissue Antigens 61(5):335–343

    Article  PubMed  CAS  Google Scholar 

  16. Coca S, Perez-Piqueras J et al (1997) “The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma.” Cancer 79(12):2320–2328

    Article  PubMed  CAS  Google Scholar 

  17. Colucci F, Caligiuri MA et al (2003) “What does it take to make a natural killer?” Nat Rev Immunol 3(5):413–425

    Article  PubMed  CAS  Google Scholar 

  18. Cooper MA, Fehniger TA et al (2001) “The biology of human natural killer-cell subsets.” Trends Immunol 22(11):633–640

    Article  PubMed  CAS  Google Scholar 

  19. Costello RT, Sivori S et al (2002) “Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia.” Blood 99(10):3661–3667

    Article  PubMed  CAS  Google Scholar 

  20. Delale T, Paquin A et al (2005) “yD88-dependent and -independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo.” J Immunol 175(10):6723–6732

    PubMed  CAS  Google Scholar 

  21. Della Chiesa M, Vitale M et al (2003) “The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.” Eur J Immunol 33(6):1657–1666

    Article  PubMed  CAS  Google Scholar 

  22. Di Santo JP, Vosshenrich CA (2006) “Bone marrow versus thymic pathways of natural killer cell development.” Immunol Rev 214:35–46

    Article  PubMed  CAS  Google Scholar 

  23. Doherty DG, C O’Farrelly (2000) “Innate and adaptive lymphoid cells in the human liver.” Immunol Rev 174:5–20

    Article  PubMed  CAS  Google Scholar 

  24. Epling-Burnette PK, FBai et al (2007) “Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors.” Blood 109(11):4816–4824

    Article  PubMed  CAS  Google Scholar 

  25. Etzioni A, Eidenschenk C et al (2005) “Fatal varicella associated with selective natural killer cell deficiency.” J Pediatr 146(3):423–425

    Article  PubMed  Google Scholar 

  26. Facchini A, Mariani E et al (1987) “Increased number of circulating Leu 11+ (CD 16) large granular lymphocytes and decreased NK activity during human ageing.” Clin Exp Immunol 68(2):340–347

    PubMed  CAS  Google Scholar 

  27. Farag SS, MA Caligiuri (2006) “Human natural killer cell development and biology.” Blood Rev 20(3):123–137

    Article  PubMed  CAS  Google Scholar 

  28. Farag SS, Fehniger TA et al (2002) “Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect.” Blood 100(6):1935–1947

    Article  PubMed  CAS  Google Scholar 

  29. Fauriat C, Moretta A et al (2005) “Defective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patients.” Blood 106(6):2186–2188

    Article  PubMed  CAS  Google Scholar 

  30. Ferlazzo G., Tsang ML et al (2002) “Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells.” J Exp Med 195(3):343–351

    Article  PubMed  CAS  Google Scholar 

  31. Ferlazzo G, C Munz (2004) “NK cell compartments and their activation by dendritic cells.” J Immunol 172(3):1333–1339

    PubMed  CAS  Google Scholar 

  32. Frey M, Packianathan NB et al (1998) “Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets.” J Immunol 161(1):400–408

    PubMed  CAS  Google Scholar 

  33. Gazit R, Garty BZ et al (2004) “Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome.” Blood 103(5):1965–1966

    Article  PubMed  CAS  Google Scholar 

  34. Golab J (2000) “Interleukin 18–interferon gamma inducing factor–a novel player in tumour immunotherapy?” Cytokine 12(4):332–338

    Article  PubMed  CAS  Google Scholar 

  35. Hamblin TJ (1996) “Immunological abnormalities in myelodysplastic syndromes.” Semin Hematol 33(2):150–162

    PubMed  CAS  Google Scholar 

  36. Imai K, Matsuyama S et al (2000) “Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population.” Lancet 356(9244):1795–1799

    Article  PubMed  CAS  Google Scholar 

  37. Ishigami S, Natsugoe S et al (2000) “Prognostic value of intratumoral natural killer cells in gastric carcinoma.” Cancer 88(3):577–583

    Article  PubMed  CAS  Google Scholar 

  38. Iversen AC, Norris PS et al (2005) “Human NK cells inhibit cytomegalovirus replication through a noncytolytic mechanism involving lymphotoxin-dependent induction of IFN-beta.” J Immunol 175(11):7568–7574

    PubMed  CAS  Google Scholar 

  39. Jacobs R, Hintzen G et al (2001) “CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells.” Eur J Immunol 31(10):3121–3127

    Article  PubMed  CAS  Google Scholar 

  40. Jawahar S, Moody C et al (1996) “Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II).” Clin Exp Immunol 103(3):408–413

    PubMed  CAS  Google Scholar 

  41. Komiyama A, Kawai H et al (1990) “Natural killer cell immunodeficiency in siblings: defective killing in the absence of natural killer cytotoxic factor activity in natural killer and lymphokine- activated killer cytotoxicities.” Pediatrics 85(3):323–330

    PubMed  CAS  Google Scholar 

  42. Krug A, French AR et al (2004) “ TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function.” Immunity 21(1):107–119

    Article  PubMed  CAS  Google Scholar 

  43. Lanier LL, Le AM et al (1986) “ The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.” J Immunol 136(12):4480–4486

    PubMed  CAS  Google Scholar 

  44. Lauwerys BR, Garot N et al (2000) “Cytokine production and killer activity of NK/TNK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.” J Immunol 165(4):1847–1853

    PubMed  CAS  Google Scholar 

  45. Lian RH, V Kumar (2002) “Murine natural killer cell progenitors and their requirements for development.” Semin Immunol 14(6):453–460

    Article  PubMed  CAS  Google Scholar 

  46. Lopez C, Kirkpatrick D et al (1983) “Correlation between low natural killing of fibroblasts infected with herpes simplex virus type 1 and susceptibility to herpesvirus infections.” J Infect Dis 147(6):1030–1035

    PubMed  CAS  Google Scholar 

  47. McNerlan SE, Rea IM et al (1998) “Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging.” J Clin Immunol 18(1):31–38

    Article  PubMed  CAS  Google Scholar 

  48. Miyaji C, Watanabe H et al (2000) “Functional alteration of granulocytes, NK cells, and natural killer T cells in centenarians.” Hum Immunol 61(9):908–916

    Article  PubMed  CAS  Google Scholar 

  49. Mocikat R, Braumuller H et al (2003) “Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses.” Immunity 19(4):561–569

    Article  PubMed  CAS  Google Scholar 

  50. Moretta A (2002) “Natural killer cells and dendritic cells: rendezvous in abused tissues.” Nat Rev Immunol 2(12):957–964

    Article  PubMed  CAS  Google Scholar 

  51. Moretta L, Bottino C et al (2006) “Surface NK receptors and their ligands on tumor cells.” Semin Immunol 18(3):151–158

    Article  PubMed  CAS  Google Scholar 

  52. Moretta L, Ferlazzo G et al (2006) “Effector and regulatory events during natural killer-dendritic cell interactions.” Immunol Rev 214:219–228

    Article  PubMed  CAS  Google Scholar 

  53. Moretta L, A Moretta (2004) “Killer immunoglobulin-like receptors.” Curr Opin Immunol 16(5):626–633

    Article  PubMed  CAS  Google Scholar 

  54. Moretta L, A Moretta (2004) “Unravelling natural killer cell function: triggering and inhibitory human NK receptors.” Embo J 23(2):255–259

    Article  PubMed  CAS  Google Scholar 

  55. Mrozek E, Anderson P et al (1996) “Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells.” Blood 87(7):2632–2640

    PubMed  CAS  Google Scholar 

  56. Nagler A, Lanier LL et al (1989) “Comparative studies of human FcRIII-positive and negative natural killer cells.” J Immunol 143(10):3183–3191

    PubMed  CAS  Google Scholar 

  57. Notarangelo L, Casanova JL et al (2004) “Primary immunodeficiency diseases: an update.” J Allergy Clin Immunol 114(3):677–687

    Article  PubMed  CAS  Google Scholar 

  58. Ogata K (2006) “Myelodysplastic syndromes: recent progress in diagnosis and understanding of their pathophysiology.” J Nippon Med Sch 73(6):300–307

    Article  PubMed  CAS  Google Scholar 

  59. Ogata K, An E et al (2001) “Association between natural killer cell activity and infection in immunologically normal elderly people.” Clin Exp Immunol 124(3):392–397

    Article  PubMed  CAS  Google Scholar 

  60. Ogata K, Yokose N et al (1994) “Assessment of therapeutic potential of interleukin 2 for myelodysplastic syndromes.” Br J Haematol 86(3):562–567

    Article  PubMed  CAS  Google Scholar 

  61. Ogata K, Yokose N et al (1997) “Natural killer cells in the late decades of human life.” Clin Immunol Immunopathol 84(3):269–275

    Article  PubMed  CAS  Google Scholar 

  62. Orange JS (2002) “Human natural killer cell deficiencies and susceptibility to infection.” Microbes Infect 4(15):1545–1558

    Article  PubMed  CAS  Google Scholar 

  63. Parrish-Novak J, Dillon SR et al (2000) “Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function.” Nature 408(6808):57–63

    Article  PubMed  CAS  Google Scholar 

  64. Pende D, Castriconi R et al (2006) “Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction.” Blood 107(5):2030–2036

    Article  PubMed  CAS  Google Scholar 

  65. Pende D, Parolini S et al (1999) “Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells.” J Exp Med 190(10):1505–1516

    Article  PubMed  CAS  Google Scholar 

  66. Pende D, Rivera P et al (2002) “Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.” Cancer Res 62(21):6178–6186

    PubMed  CAS  Google Scholar 

  67. Robertson MJ (2002) “Role of chemokines in the biology of natural killer cells.” J Leukoc Biol 71(2):173–183

    PubMed  CAS  Google Scholar 

  68. Rodella L, Zamai L et al (2001) “Interleukin 2 and interleukin 15 differentially predispose natural killer cells to apoptosis mediated by endothelial and tumour cells.” Br J Haematol 115(2):442–450

    Article  PubMed  CAS  Google Scholar 

  69. Sansoni P, Cossarizza A et al (1993) “Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians.” Blood 82(9):2767–2773

    PubMed  CAS  Google Scholar 

  70. Semino C, Angelini G. et al (2005) “NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1.” Blood 106(2):609–616

    Article  PubMed  CAS  Google Scholar 

  71. Siren J, Sareneva T et al (2004) “Cytokine and contact-dependent activation of natural killer cells by influenza A or Sendai virus-infected macrophages.” J Gen Virol 85(Pt 8):2357–2364

    Article  PubMed  CAS  Google Scholar 

  72. Sivori S, Carlomagno S et al (2006) “Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells.” Eur J Immunol 36(4):961–967

    Article  PubMed  CAS  Google Scholar 

  73. Su H C, Ishikawa R et al (1993) “Transforming growth factor-beta expression and natural killer cell responses during virus infection of normal, nude, and SCID mice.” J Immunol 151(9):4874–4890

    PubMed  CAS  Google Scholar 

  74. Tabeta K, Georgel P et al (2004) “Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection.” Proc Natl Acad Sci U S A 101(10):3516–3521

    Article  PubMed  CAS  Google Scholar 

  75. Vankayalapati R, Garg A et al (2005). “Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium.” J Immunol 175(7):4611–4617

    PubMed  CAS  Google Scholar 

  76. Villegas FR, Coca S et al (2002) “Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer.” Lung Cancer 35(1):23–28

    Article  PubMed  Google Scholar 

  77. Vitale M, Della Chiesa M et al (2005) “NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor.” Blood 106(2):566–571

    Article  PubMed  CAS  Google Scholar 

  78. Wack A, Cossarizza A et al (1998) “Age-related modifications of the human alphabeta T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets.” Int Immunol 10(9):1281–1288

    Article  PubMed  CAS  Google Scholar 

  79. Waldmann TA, Dubois S et al (2001) “Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy.” Immunity 14(2):105–110

    PubMed  CAS  Google Scholar 

  80. Welsh RM (1981) “Natural cell-mediated immunity during viral infections.” Curr Top Microbiol Immunol 92:83–106

    PubMed  CAS  Google Scholar 

  81. Welsh RM, Brubaker JO et al (1991) “Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK celldependent control of virus infections occur independently of T and B cell function.” J Exp Med 173(5):1053–1063

    Article  PubMed  CAS  Google Scholar 

  82. Wendland T, Herren S et al (2000) “Strong alpha beta and gamma delta TCR response in a patient with disseminated Mycobacterium avium infection and lack of NK cells and monocytopenia.” Immunol Lett 72(2):75–82

    Article  PubMed  CAS  Google Scholar 

  83. Wikby A, Maxson P et al (1998) “Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study.” Mech Ageing Dev 102(2–3):187–198

    Article  PubMed  CAS  Google Scholar 

  84. Williamson PJ, Kruger AR et al (1994) “Establishing the incidence of myelodysplastic syndrome.” Br J Haematol 87(4):743–745

    Article  PubMed  CAS  Google Scholar 

  85. Yokose N, Ogata K et al (1994) “Elevated plasma soluble interleukin 2 receptor level correlates with defective natural killer and CD8 +T-cells in myelodysplastic syndromes.” Leuk Res 18(10):777–782

    Article  PubMed  CAS  Google Scholar 

  86. Zamai L, Ponti C et al (2007) “NK cells and cancer.” J Immunol 178(7):4011–4016

    PubMed  CAS  Google Scholar 

  87. Zitvogel L (2002) “Dendritic and natural killer cells cooperate in the control/switch of innate immunity.” J Exp Med 195(3):F9–F14

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology Department of Medicine, Nippon Medical School, 1-1-5 Sendagi, 113-8603, Bunkyo-ku, Tokyo, Japan

    Hideto Tamura & Kiyoyuki Ogata

Authors
  1. Hideto Tamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kiyoyuki Ogata
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Research Center on Aging, Department of Medicine, Immunology Graduate Programme, Faculty of Medicine, University of Sherbrooke, 1036 Rue Belvedere, J1H 4C4, Sherbrooke, Quebec, Canada

    Tamas Fulop

  2. Department of Experimental Pathalogy, CIG Interdepartmental Center “L. Galvani” University of Bologna, Via San Giacomo 12, 40126, Bologna, Italy

    Claudio Franceschi

  3. Institute for Health and Life Sciences, 4-6-22 Kohinato, Bunkyo-ku, Tokyo, 112-0006, Japan

    Katsuiku Hirokawa

  4. ZMF - Zentrum Med. Forschung Abt. Transplant./ Immunologie, University of Tübingen, Waldhörnlestr. 22, 72072, Tübingen, Germany

    Graham Pawelec

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Tamura, H., Ogata, K. (2009). Natural Killer Cells and Human Longevity. In: Fulop, T., Franceschi, C., Hirokawa, K., Pawelec, G. (eds) Handbook on Immunosenescence. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9063-9_28

Download citation

Publish with us

Policies and ethics

Search

Navigation